Edward Chow
@echow310
Followers
118
Following
254
Media
0
Statuses
16
Assoc. Prof & Research Director, Pharmacology Dept, NUS; PI @ CSI_Singapore; Interest: Tomorrow's tech that improves cancer treatment today
Singapore
Joined April 2009
Is #personalization of drug combinations possible/ feasible in cancer care? Check out our latest publication in @ScienceTM: https://t.co/rXZJCA9bhA. Fantastic collaboration with @echow310 and clinical/ scientific colleagues @NUSMedicine @SingHealthSG @csi_singapore 1/n
9
23
59
Great work led by @ChesterLeeDrum
#Bioorthogonal catalysis: self-assembling, porous exoshells encapsulate and deliver an iron-containing reaction center for the treatment of #BreastCancer, by Chester Drum and co-workers https://t.co/Y2yDPVshp9
0
1
0
Really chuffed to have our work accepted as an oral presentation at #ASH2021
https://t.co/TmlOYax45A We report our clinical experience with #personalized combination treatments in relapsed #lymphoma - a fantastic collaboration with @echow310 and colleagues across Singapore.
6
8
57
DEADLINE EXTENDED! The closing date for abstract submission has been extended to 11 January 2021. Submit your abstracts today:
Do not miss the opportunity to present your research at the Epigenetics in Cancer Symposium 2021! Abstract submission closes on 28 December. Submit your abstract today!
0
1
4
Our bond free premium scholarship provides you with the opportunity to work with a dynamic team of renowned scientists in an intellectually stimulating environment. Apply for the CSI PhD Graduate Program now! https://t.co/EhapbVK9G6
0
7
5
Do not miss the opportunity to present your research at the Epigenetics in Cancer Symposium 2021! Abstract submission closes on 28 December. Submit your abstract today!
Abstract submission is now OPEN for the Epigenetics in Cancer Symposium 2021! Find out more here: https://t.co/AKF9EE8lVY Register today at: https://t.co/dIfAFwFNoX
0
1
2
It was a privilege working with an amazing team on this paper @TrendsinBiotech! @WeAreWisDM @TheN1Institute @BME_NUS @chngwj @PersonalizedMed @The__Liver @echow310
Enabling Technologies for Personalized and Precision Medicine #artificialintelligence @TrendsinBiotech @thedeanh @TheN1Institute @BME_NUS
https://t.co/L43WoyaeMt
0
2
18
Abstract submission is now OPEN for the Epigenetics in Cancer Symposium 2021! Find out more here: https://t.co/AKF9EE8lVY Register today at: https://t.co/dIfAFwFNoX
0
2
4
The Epigenetics in Cancer Symposium (15-17 Feb 2021) is a high profile conference with a lineup of internationally distinguished speakers. Registration is now open: https://t.co/9WHFeIKXsv More info available here: https://t.co/GEKKYI8Dhe
@denniskappei @DefossezPierre
0
1
4
ICYMI: The NADIM study: #Neoadjuvant #chemotherapy and #nivolumab in resectable non-small-cell #lungcancer: an open-label, multicentre, single-arm, phase 2 trial #NSCLC #lcsm
0
7
11
Check out our recent paper in Adv. Mat. on non-genetic modifications of cells by depositing nano-complexes of biomomecules on cell surfaces. Anti-PDL1 nano-complexes on macrophages markedly improved tumor response in mice https://t.co/4bPjlJ1yKV
@wyssinstitute @hseas
5
11
128
Free registration is open for the virtual @CSI_Singapore Frontiers in Cancer Science Annual Conference, Nov 2-6. We are partnering with FCS to organize three AACR-FCS Education Sessions for graduate students and early-career investigators. Learn more: https://t.co/QCCUh7Q0tf
0
10
7
Good things happen when engineering principles are applied to cancer research and drug development. Enjoyed this review by @khademh about AI/Engineering applied towards IO. #ArtificialIntelligence #oncology #Immunotherapy
0
2
14
A recent review in our SLAS Technology comprehensively covers how AI is applied at every step of drug development, from target identification to patient stratification. #ArtificialIntelligence #Pharmaceutical #PrecisionMedicine #SLAS
https://t.co/u8n7Mnn7zh
journals.sagepub.com
The inverse relationship between the cost of drug development and the successful integration of drugs into the market has resulted in the need for innovative so...
0
1
7